Derek Adams

Derek Adams is an experienced executive in the biotechnology and pharmaceutical sectors, serving as CEO and President of Stellular Bio since November 2022, focusing on platelet-derived regenerative biologic therapy. Additionally, Derek holds a board position at AlloVir and previously led PlateletBio as President and CEO, overseeing a strategic shift to acellular regenerative medicine. With a strong background in technical and operational roles, Derek has held senior positions at bluebird bio, Evelo Biosciences, and Alexion Pharmaceuticals, where responsibilities included manufacturing, quality assurance, and product development, along with significant achievements in scaling operations and launching multiple products. Derek holds a Ph.D. in Chemical Engineering from the University of Minnesota and a B.S. in Chemical Engineering from Worcester Polytechnic Institute, complemented by business training at Harvard Business School.